For TJA, priority endpoints include wound complications, prolonged drainage, hematoma requiring intervention, early readmission, and PJI, with follow-up sufficient to capture early revision risk
Adequate hydration is particularly important for people taking retatrutide, as nausea and vomiting the most commonly reported gastrointestinal side effects in clinical trials can lead to fluid and electrolyte losses
Just started with this & have noticed some energy boost
Lilly has demonstrated their ability to bring complex peptide therapies through the regulatory process, and their phase 3 TRIUMPH trial program for retatrutide includes multiple studies across different patient populations
It's a compound with immense promise, offering a sophisticated, targeted approach to one of biology's most complex challenges